AID Genomics has developed a purpose-built program for the establishment of diagnostic clinical-grade NGS-based laboratories, and together with local business partners will leverage their ability to successfully create a financially healthy venture, which provides clinical solutions to the international markets’ needs for diagnostic services and maintains a substantial edge over competitors.
The program is to establish molecular-diagnostic labs using AID Genomics proprietary know-how and expertise. The laboratories will focus on transforming advanced genome-sequencing services into a cutting-edge diagnostic clinical labs all while providing a scalable business model that provides a rapid, high ROI.
The Benefits of Collaborating with GeneSort:
Immediate access to methods and products, based on proven know-how and trade secrets.
Expanding product portfolio based on continuous innovative R&D.
Streamlined production procedures.
Active QC, certification, regulation, compliance and training support.
Connection to in-house bioinformatics and big data services.
Inclusion in agreements reached with international health care providers and insurance companies.
ROI within a period of 4 years.
Laboratory Model Types:
Each LLP plan will be matched to standard laboratory model types defining:
Types of tests and services.
Production capacity – number of tests per month.
Laboratory size (net area).
Equipment requirements and specifications.
TOT support package.
Local workforce – job descriptions and qualifications.